EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems

Sourabh Kundu, Gitika Kumari, Dadi A. Srinivasarao

RSC Pharmaceutics · 2025 · 2 (5) · 1050-1077

DOI: 10.1039/d5pm00068h ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Pharmaceutics, 2025. Verfasst von Sourabh Kundu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, Science and Engineering Research Board, Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article discusses emerging ophthalmic drug delivery systems such as nanoparticles and stimuli-responsive systems for non-invasive or minimally invasive glaucoma therapy.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology
  • Science and Engineering Research Board
  • Indian Council of Medical Research

Zitieren

APA

Kundu, S., Kumari, G., & Srinivasarao, D. A. (2025). Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems. RSC Pharmaceutics, 2(5), 1050-1077. https://doi.org/10.1039/d5pm00068h

Vancouver

Kundu S, Kumari G, Srinivasarao DA. Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems. RSC Pharmaceutics. 2025;2(5):1050-1077. doi:10.1039/d5pm00068h

BibTeX
@article{Kundu2025,
  author = {Kundu, Sourabh and Kumari, Gitika and Srinivasarao, Dadi A.},
  title = {Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems},
  journal = {RSC Pharmaceutics},
  year = {2025},
  volume = {2},
  number = {5},
  pages = {1050--1077},
  doi = {10.1039/d5pm00068h}
}
Kostenlos starten →